{
    "code": "52027643",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027643",
    "time": "2024-02-15 22:55:14",
    "許可證字號": "衛部藥輸字第027643號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/05\/14",
    "發證\/登錄日期": "108\/05\/14",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202764300",
    "中文品名": "捷癌寧膜衣錠50毫克",
    "英文品名": "VERZENIO film-coated tablet 50mg",
    "適應症": "1. 早期乳癌：併用內分泌療法 (tamoxifen或芳香環酶抑制劑 )，可做為荷爾蒙受體(HR)陽性、第二型人類表皮生長因子受體(HER2)陰性、淋巴結陽性，高復發風險之早期乳癌成年病人的輔助治療。\r\n2. 晚期乳癌：\r\n(1) 併用芳香環酶抑制劑(aromatase inhibitor)，可做為治療荷爾蒙受體(HR)陽性、第二型人類表皮生長因子受體(HER2)陰性之晚期或轉移性乳癌之停經後婦女及男性的第一線內分泌療法(endocrine-based therapy)。\r\n(2) 併用fulvestrant，可治療荷爾蒙受體(HR)陽性、第二型人類表皮生長因子受體(HER2)陰性，且接受內分泌療法後疾病惡化之晚期或轉移性乳癌的成人病人。\r\n(3) 單獨用於治療荷爾蒙受體(HR)陽性、第二型人類表皮生長因子受體(HER2)陰性，曾經接受過內分泌治療及於轉移後接受化學治療後又發生疾病惡化之晚期或轉移性乳癌的成人病人。",
    "劑型": "116膜衣錠",
    "包裝": "12-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分;",
    "監視期限": "113\/05\/14",
    "主成分略述": "abemaciclib",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "台灣禮來股份有限公司",
    "申請商地址": "台北市復興北路３６５號１１樓",
    "主製造廠": [
        {
            "製造廠名稱": "LILLY DEL CARIBE INC.",
            "製造廠廠址": "12.6 KM 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICO",
            "製造廠公司地址": "",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "LILLY S.A.",
            "製造廠廠址": "AVDA DE LA INDUSTRIA 30 28108 ALCOBENDAS MADRID SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200045000",
            "成分名稱": "abemaciclib",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "50mg 鋁箔_正反-109-08-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=004&Type=10"
        },
        {
            "title": "50mg 錠劑_正反-109-08-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "VERZENIO 依核定草本修改之仿單_20220302-111-03-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=004&Type=9"
        },
        {
            "title": "50mg 外盒_正反-109-08-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=004&Type=8"
        },
        {
            "title": "020276430003_鋁箔-108-06-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=002&Type=8"
        },
        {
            "title": "020276430002_外盒-108-06-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027643&Seq=001&Type=8"
        }
    ]
}